Cargando…
Serum anti-malondialdehyde-acetaldehyde IgA antibody concentration improves prediction of coronary atherosclerosis beyond traditional risk factors in patients with rheumatoid arthritis
Patients with rheumatoid arthritis (RA) have increased atherosclerosis; oxidative stress may be a contributor. Oxidative stress produces immunogenic malondialdehyde-acetaldehyde (MAA) protein adducts and anti-MAA antibodies are detectable in human serum. We hypothesized that anti-MAA antibody concen...
Autores principales: | Lomzenski, Hannah E., Thiele, Geoffrey M., Duryee, Michael J., Chen, Sheau-Chiann, Ye, Fei, Anderson, Daniel R., Mikuls, Ted R., Ormseth, Michelle J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217813/ https://www.ncbi.nlm.nih.gov/pubmed/35732827 http://dx.doi.org/10.1038/s41598-022-14954-9 |
Ejemplares similares
-
Citrullinated and malondialdehyde-acetaldehyde modified fibrinogen activates macrophages and promotes an aggressive synovial fibroblast phenotype in patients with rheumatoid arthritis
por: Aripova, Nozima, et al.
Publicado: (2023) -
Unique Antibody Responses to Malondialdehyde-Acetaldehyde (MAA)-Protein Adducts Predict Coronary Artery Disease
por: Anderson, Daniel R., et al.
Publicado: (2014) -
Direct antioxidant properties of methotrexate: Inhibition of malondialdehyde-acetaldehyde-protein adduct formation and superoxide scavenging
por: Zimmerman, Matthew C., et al.
Publicado: (2017) -
Malondialdehyde-Acetaldehyde Modified (MAA) Proteins Differentially Effect the Inflammatory Response in Macrophage, Endothelial Cells and Animal Models of Cardiovascular Disease
por: Duryee, Michael J., et al.
Publicado: (2021) -
Malondialdehyde-acetaldehyde (MAA) modified proteins induce pro-inflammatory and pro-fibrotic responses by liver endothelial cells
por: Thiele, Geoffrey M, et al.
Publicado: (2004)